Related Experiment Video
Updated: Jul 6, 2026

Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells
Published on: February 20, 2015
Role of microparticles in atherothrombosis
A S Leroyer1, A Tedgui, C M Boulanger
1Institut National de la Santé et de la Recherche Médicale (Unit 689), Cardiovascular Research Institute Inserm, Paris, France.
Abstract:
Cell activation or apoptosis leads to plasma membrane blebbing and microparticle (MP) release in the extracellular space. MPs are submicron membrane vesicles which express a panel of phospholipids and proteins specific of the cells they are derived from. Exposure of negatively charged phospholipids and tissue factor confers a procoagulant potential to MPs. MPs accumulate in the lipid core of the atherosclertotic plaque and is a major determinant of its thrombogenecity. Elevation of plasma MPs levels, particularly those of endothelial origin, reflects cellular injury and is considered now as a surrogate marker of vascular dysfunction. Thus, MPs can be seen as triggers of a vicious circle for they promote prothrombogenic and pro-inflammatory responses as well as cellular dysfunction within the vascular compartment. A better knowledge of MP composition and biological effects as well as the mechanisms leading to their clearance will probably open new therapeutic approaches in the treatment of atherothrombosis.
Insights
Microparticles (MPs) are released from activated cells and contribute to atherosclerosis by promoting blood clots and inflammation. Understanding MP clearance could lead to new atherothrombosis treatments.
Area of Science:
- Cardiovascular Biology
- Cellular Biology
- Biochemistry
Background:
- Cell activation or apoptosis releases microparticles (MPs), which are submicron membrane vesicles.
- MPs carry cell-specific phospholipids and proteins, including those conferring procoagulant potential.
- MPs accumulate in atherosclerotic plaques, increasing thrombogenicity and reflecting vascular dysfunction.
Purpose of the Study:
- To review the role of microparticles in atherothrombosis.
- To highlight MPs as markers of cellular injury and vascular dysfunction.
- To explore potential therapeutic strategies targeting MP biology.
Main Methods:
- Literature review on microparticle formation, composition, and function.
- Analysis of the role of MPs in atherothrombosis pathogenesis.
- Discussion of MP clearance mechanisms and therapeutic implications.
Main Results:
- MPs promote prothrombotic and pro-inflammatory responses.
- Elevated plasma MP levels, especially endothelial MPs, indicate cellular injury and vascular dysfunction.
- MPs contribute to a cycle of vascular dysfunction and atherothrombosis.
Conclusions:
- Microparticles play a critical role in the pathogenesis of atherothrombosis.
- MPs serve as important biomarkers for vascular health.
- Further research into MP composition, effects, and clearance may yield novel therapeutic interventions for atherothrombosis.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Micelles
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Atherosclerosis I: Introduction
Peripheral Artery Disease I: Introduction

